Impact BioMedical Inc [AMEX: IBO] gained 107.48% or 0.5 points to close at $0.96 with a heavy trading volume of 115250507 shares.
The daily chart for IBO points out that the company has recorded -48.24% loss over the past six months.
If we look at the average trading volume of 3.99M shares, IBO reached to a volume of 115250507 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Impact BioMedical Inc [IBO]:
The Average True Range (ATR) for Impact BioMedical Inc is set at 0.70 The Price to Book ratio for the last quarter was 2.64, with the Price to Cash per share for the same quarter was set at 0.17.
Trading performance analysis for IBO stock
Impact BioMedical Inc [IBO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -36.66. With this latest performance, IBO shares dropped by -20.44% in over the last four-week period, additionally sinking by -48.24% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IBO stock in for the last two-week period is set at 45.24, with the RSI for the last a single of trading hit 44.05, and the three-weeks RSI is set at 45.89 for Impact BioMedical Inc [IBO]. The present Moving Average for the last 50 days of trading for this stock 1.6658, while it was recorded at 0.7373 for the last single week of trading.
Impact BioMedical Inc [IBO]: A deeper dive into fundamental analysis
Impact BioMedical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.25 and a Current Ratio set at 0.25.
An analysis of Institutional ownership at Impact BioMedical Inc [IBO]
There are presently around $1.89%, or 4.22%% of IBO stock, in the hands of institutional investors.
